Rare Ebola Outbreak in Congo Nears 1,000 Suspected Cases, Strains Response
A rare and untreatable strain of Ebola is spreading rapidly in eastern Democratic Republic of Congo, with suspected cases nearing 1,000 and more than 220 suspected deaths. The World Health Organization (WHO) has declared a global health emergency as the Bundibugyo virus, for which there is no vaccine, spreads in a conflict-ridden region where health facilities have been attacked. International aid is being mobilized, but responders face immense challenges.
Facts First
- Suspected Ebola cases are nearing 1,000 in eastern Congo, with over 220 suspected deaths.
- The outbreak involves the rare Bundibugyo type of Ebola, which currently has no vaccine or approved treatment.
- The World Health Organization (WHO) has declared the outbreak a public health emergency of international concern.
- At least three attacks on healthcare facilities occurred in recent weeks, including arson at treatment centers.
- International aid is being deployed, with the U.S. pledging $23 million and the U.N. releasing $60 million for the response.
What Happened
An outbreak of the rare Bundibugyo strain of Ebola was confirmed in eastern Democratic Republic of Congo. As of Monday, May 25, 2026, suspected cases are nearing 1,000, with more than 220 suspected deaths, according to WHO Director-General Tedros Adhanom Ghebreyesus. The virus spread undetected for weeks because initial tests were conducted for a more common type of Ebola. The outbreak has been declared a public health emergency of international concern by the WHO. In recent weeks, at least three attacks have occurred against healthcare facilities, including an incident on Sunday where young men stormed a hospital treating Ebola patients, forcing staff to evacuate amid gunfire.
Why this Matters to You
The risk of global spread is currently assessed as low by the WHO. However, the outbreak highlights the fragility of global health surveillance, especially in conflict zones, and could lead to increased travel restrictions. For those in the affected region, the outbreak is devastating: the lack of a vaccine for this strain leaves communities vulnerable, attacks on treatment centers hinder care, and the price of basic disinfectants has reportedly quadrupled in some areas. The situation may also strain international aid resources.
What's Next
Response efforts are being scaled up, with the U.S. pledging to fund up to 50 emergency treatment clinics and the U.N. releasing emergency funds. However, an expert stated a vaccine for the Bundibugyo strain would not be available for at least six to nine months. The outbreak's containment faces significant hurdles, including ongoing conflict, community mistrust evidenced by the attacks on health centers, and the challenges of contact tracing in a highly mobile population. The WHO and other agencies are working to strengthen cross-border surveillance with neighboring Uganda and South Sudan.